Skip to main content

2021 healthcare headlines.

When it comes to the news cycle, keeping up with the latest information can get pretty exhausting. We’re constantly getting updates sent to our devices, oftentimes receiving a notification, typically unprovoked, from our preferred source of news. To help round up some of the most important headlines coming out of 2021, we’ve collected a short list of articles that left a great impact. Read on to get up to speed.

Experimental Alzheimer’s drug could slow cognitive decline in patients, early results suggest.
By Lauren Mascarenhas, CNN
In March 2021, early clinical trial results had shown that Eli Lilly and Company’s experimental intravenous drug donanemab could potentially slow down the cognitive decline of patients with Alzheimer’s.

Amazon is launching its medical care business for its employees and other companies across the US.
By Blake Dodge, Business Insider
In March 2021, Amazon announced that its telehealth service for employees and other companies, Amazon Care, would roll out in all 50 states starting in summer 2021. The service aims to help with virtual doctor visits, diagnostic labs, prescription deliveries, and more.

In controversial decision, FDA approves first new Alzheimer’s disease drug in nearly 20 years.
By Jacqueline Howard, CNN
In June 2021, the FDA approved the use of experimental drug aducanumab for early phases of Alzheimer’s. Despite approval, there had been controversy surrounding the evidence that supports the effectiveness of the treatment.

The FDA authorizes COVID booster shots for all US adults.
By Scott Neuman, NPR
In November 2021, the FDA granted an Emergency Use Authorization for a third dose of the Pfizer-BioNTech and Moderna vaccines.

What to know about the omicron variant of the coronavirus.
By Meryl Kornfield, Adela Suliman, María Luisa Paúl and Lindsey Bever, The Washington Post
In late November 2021, news spread around the latest COVID-19 variant, omicron. According to findings published in The Washington Post, the variant had reported an unusually high number of mutations, with early research showing that a booster shot could grant protection from severe symptoms in omicron infection.

Man says he feels cured after living with diabetes for almost 50 years.
By Doug Vollmayer and Katie Kindelan, Good Morning America
Last month, a potentially life-changing treatment by Vertex Pharmaceuticals made waves as clinical trial participant Brian Shelton claimed that he had been cured of type 1 diabetes.

Amazon Alexa’s new elder care service launches today.
By Jennifer Pattison Tuohy, The Verge
Another trending story from last month – Amazon officially launched Alexa Together, a new subscription service designed to offer a minimally invasive way to use its voice assistant and speakers to assist and keep tabs on elderly loved ones or individuals that require a caregiver.

For more of the latest healthcare news, visit or follow Praxis on FacebookTwitter, and LinkedIn.